Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression [Phase 2]
Phase 2 trial evaluating repeated partial sleep deprivation to augment SSRI response in depression has completed with results posted in 2015…
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: Magnetic Seizure Therapy (MST) for Severe Mood Disorder [Phase 3]
Phase 3 clinical trial evaluating Magnetic Seizure Therapy for severe mood disorder has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Mobile-Web Emotion Self-management Tool [Phase 2]
A Phase 2 trial of a mobile-web emotion self-management tool for stress and depression has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Expressive Writing for Co-Occurring Depression and Alcohol Misuse [NA]
A Baylor College of Medicine trial investigating expressive writing as a non-drug intervention for co-occurring depression and alcohol use d…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 3]
Phase 3 trial evaluating armodafinil as adjunctive therapy for major depressive episodes in adults with Bipolar I disorder; results were pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 3]
A Phase 3 study evaluated armodafinil 150 mg/day as adjunctive therapy for adults with major depression associated with bipolar I disorder; …
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 3]
Phase 3 trial evaluating armodafinil as adjunctive therapy for adults with major depressive episodes associated with bipolar I disorder has …
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder [Phase 3]
Phase 3 extension study update for armodafinil as adjunctive therapy in adults with major depression associated with Bipolar I Disorder; stu…
-
FDA approval · 2015-01-16FDA Approved: MIRTAZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for the generic antidepressant mirtazapine from Aurobindo Pharma Limited.
-
FDA approval · 2015-01-16FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application for Mirtazapine from Aurolife Pharma LLC (ANDA 076921). The action reflects a regulatory approval re…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Auricular Acupuncture vs. Progressive Muscle Relaxation in Patients With Anxiety Disorders or Major Depressive Disorder. [NA]
A completed clinical trial compared auricular acupuncture with progressive muscle relaxation in patients with anxiety disorders or major dep…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Yoga for Stress and Mental Health [NA]
A completed clinical trial from Southern Methodist University evaluated yoga as an intervention for physiological stress and psychological d…
-
CLINICAL_TRIALS withdrawal · 2015-01-14Clinical Trial Update: Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial [EARLY_Phase 1]
The EARLY_PHASE1 randomized controlled trial evaluating an online bulletin board for depression has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram [Phase 2]
Phase 2 clinical trial evaluating creatine as treatment for female adolescents with major depressive disorder who did not respond to fluoxet…
-
FDA approval · 2015-01-12FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for a generic fluoxetine product (ANDA 076458) from Chartwell Governmental & Specialty RX, LLC. This…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Cradling Our Future Through Family Strengthening Study [NA]
A completed clinical trial by Johns Hopkins assessing a family-strengthening intervention for substance use disorders and postpartum depress…
-
CLINICAL_TRIALS research · 2015-01-12Clinical Trial Update: Internet Program for Workers With Subthreshold Depression [NA]
Clinical trial status update for an internet-based program targeting workers with subthreshold depression; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: SimCoach Evaluation: A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression [NA]
The study completed an evaluation of SimCoach, a virtual human intervention designed to encourage servicemembers to seek help for PTSD and d…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness [NA]
Clinical trial update on the In SHAPE fitness intervention for adults with serious mental illness indicates the study status is COMPLETED. T…
-
FDA approval · 2015-01-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for desipramine hydrochloride (Actavis Pharma, Inc.), updating the labeling for the product unde…
-
FDA approval · 2015-01-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for desipramine hydrochloride (a generic antidepressant).
-
FDA approval · 2015-01-05FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride (Actavis Pharma, Inc.).
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis [Phase 4]
A Phase 4 clinical trial update investigates using machine learning to predict antidepressant treatment response in major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Peer Support for Severe Mental Disorders [NA]
Completed clinical trial evaluating peer support interventions for severe mental disorders, including psychosis, major depressive disorder, …
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Project to Improve Symptoms and Mood in People With Spinal Cord Injury [Phase 4]
Phase 4 trial in people with spinal cord injury evaluating mood and related symptoms has completed; results were posted in 2015.